Astrazenaca
AstraZeneca secures MHRA licensing and NHS early access for lung cancer drug
May 7, 2021Medical Communications Astrazenaca, oncology
AstraZeneca have announced that the MHRA has granted a license extension for Tagrisso (osimertinib) in the UK, for use as …
AstraZeneca and J&J COVID-19 vaccines face viral vector shortage
March 25, 2021Astrazenaca, COVID-19, Johnson & Johnson, Vaccine
Both AstraZeneca and J&J face major manufacturing deficiencies for their recombinant vector COVID-19 vaccines, forcing competition over limited production capacity …
FDA approves AstraZeneca’s Calquence in chronic lymphoma
November 25, 2019Sales and Marketing Astrazenaca, Calquence, FDA, Health Canada, leukaemia, oncology
The FDA has approved AstraZeneca’s BTK inhibitor Calquence (acalabrutinib) in the treatment of chronic lymphocytic leukaemia (CLL) and small lymphocytic …
Top Ten most popular articles on Pharmafile.com this week
July 6, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Astrazenaca, Donald Trump, Pfizer, pharma, top ten
As the first week of July comes to an end we take a look over the most popular stories of …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
October 8, 2026
ESTEVE CDMO adds $17.5m to Illinois expansion
October 6, 2026
